Compare LPCN & FSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LPCN | FSI |
|---|---|---|
| Founded | 1997 | 1991 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 67.1M |
| IPO Year | 2011 | 2000 |
| Metric | LPCN | FSI |
|---|---|---|
| Price | $7.34 | $5.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 117.3K | 15.7K |
| Earning Date | 06-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.75% |
| EPS Growth | ★ 46.18 | 9.09 |
| EPS | N/A | ★ 0.09 |
| Revenue | $1,976,677.00 | ★ $15,494,325.00 |
| Revenue This Year | N/A | $4.11 |
| Revenue Next Year | $74.43 | $58.09 |
| P/E Ratio | ★ N/A | $63.33 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.52 | $3.46 |
| 52 Week High | $12.37 | $11.48 |
| Indicator | LPCN | FSI |
|---|---|---|
| Relative Strength Index (RSI) | 39.70 | 46.80 |
| Support Level | $2.87 | $5.48 |
| Resistance Level | $8.35 | $6.08 |
| Average True Range (ATR) | 0.79 | 0.18 |
| MACD | -0.17 | 0.07 |
| Stochastic Oscillator | 8.57 | 36.76 |
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.